A One-Time Gene Therapy Will Cost $3.95 Million — The Alternative Can Exceed $8 Million
FDA approval for Fayuvi gives families with Sanfilippo syndrome Type A a new option, while forcing insurers to compare a huge upfront price with years of progressive disease and care.